Evidence map›Paper›PMID 32489176›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020.

Max Augustin, Philipp Schommers, Isabelle Suárez, Philipp Koehler, Henning Gruell, Florian Klein, Christian Maurer, Petra Langerbeins, Vanessa Priesner, Kirsten Schmidt-Hellerau and 17 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. [The role of university hospitals in regional health care management for coping with the COVID-19 pandemic].Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Max AugustinUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Philipp SchommersUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Isabelle SuárezUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Philipp KoehlerUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Henning GruellGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Florian KleinGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Christian MaurerDepartment I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Köln, Düsseldorf, University of Cologne, Cologne, Germany.
Petra LangerbeinsDepartment I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Köln, Düsseldorf, University of Cologne, Cologne, Germany.
Vanessa PriesnerUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Kirsten Schmidt-HellerauUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Jakob J MalinUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Melanie StecherUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Norma JungUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Gerhard WiesmüllerPublic Health Department Cologne, Cologne, Germany.
Arne MeissnerDepartment of Hospital Hygiene and Infection Control, University Hospital Cologne, Cologne, Germany.
Janine ZweignerDepartment of Hospital Hygiene and Infection Control, University Hospital Cologne, Cologne, Germany.
Georg LangebartelsDepartment for Clinical Affairs, University of Cologne, Germany.
Felix KolibayDepartment for Clinical Affairs, University of Cologne, Germany.
Victor SuárezDepartment II of Internal Medicine (Nephrology, Rheumatology, Diabetes, and General Internal Medicine) and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Volker BurstDepartment II of Internal Medicine (Nephrology, Rheumatology, Diabetes, and General Internal Medicine) and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Philippe ValentinDepartment II of Internal Medicine (Nephrology, Rheumatology, Diabetes, and General Internal Medicine) and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Dirk SchedlerUniversity of Cologne, Medical Faculty and University Hospital Cologne, Department of Anaesthesiology and Intensive Care Medicine, Cologne, Germany.
Oliver A CornelyUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Michael HallekUniversity of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
Gerd FätkenheuerUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Jan RybnikerUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
Clara LehmannUniversity of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease (COVID-19) pandemic has caused tremendous pressure on hospital infrastructures such as emergency rooms (ER) and outpatient departments. To avoid malfunctioning of critical services because of large numbers of potentially infected patients seeking consultation, we established a COVID-19 rapid response infrastructure (CRRI), which instantly restored ER functionality. The CRRI was also used for testing of hospital personnel, provided epidemiological data and was a highly effective response to increasing numbers of suspected COVID-19 cases.

Indexed as

CoronavirusDisease OutbreaksPatient Care ManagementAdultBetacoronavirusCivil DefenseCoronavirus InfectionsCOVID-19GermanyHumansMiddle AgedPandemicsPneumonia, ViralRisk AssessmentSARS-CoV-2Tertiary Care CentersCOVID-19outbreakpandemic preparednessrisk assessmentSARS-CoV-2

Identifiers

PMID32489176
PMCPMC7268272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.